American Healthcare REIT, Inc. (AHR)

NYSE: AHR · USD

$51.4

+0.30 (+0.6%)· Recorded snapshot

Market cap	12B
Revenue (ttm)	2.5B
Net income (ttm)	121M
EPS (ttm)	$0.66
Shares out	233.2M
P/E (trailing)	77.5x
P/E (forward)	68.8x
Dividend	$1.00 (1.95%)
Volume	6,102,003
Beta	0.80

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.5B
Net income (ttm): 121M
EPS (ttm): $0.66
P/E (trailing): 77.5x
P/E (forward): 68.8x
Market cap: 12B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AMT	American Tower Corporation	85.1B	25.8x	7.5x	7.8%	+4.0%	+0.7%	Redukuj
ARE	Alexandria Real Estate Equities Inc.	6.9B	—	2.4x	0.9%	+6.6%	-45.8%	Trzymaj
CCI	Crown Castle Inc.	37.4B	46.3x	9.1x	5.1%	-7.9%	-6.2%	Sprzedaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E68.8

P25 11.8P50 26.8P75 44.2

Trailing P/E77.5

P25 14P50 22.5P75 42.8

ROE4

P25 -2P50 3.9P75 8.9

ROIC3.3

P25 0.5P50 2.5P75 4.8

Benchmarks · 1M

All AHR indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001632970
Company name	American Healthcare REIT, Inc.
Country	United States
Country code	US
CUSIP number	398182303
Earnings date	2026-11-05
Earnings time	amc
Employees	121
Employees change	7
Employees growth	6.14%
Enterprise value	$13.4B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
Industry	REIT - Healthcare Facilities
IPO date	2024-02-07
Is primary listing	Yes
Is SPAC	No
ISIN number	US3981823038
Last 10-K release date	2026-02-27
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$12B
Market cap category	Large-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$51.36
Price currency	USD
Sector	Real Estate
SIC code	6798
Stock price date	2026-10-28
Symbol	AHR
U.S. state	California
Website	https://www.americanhealthcarereit.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	73.25x
Earnings yield	1.29%
EV/Earnings	108.99x
EV/EBIT	77.08x
EV/EBITDA	29.48x
EV/FCF	67.45x
EV/Sales	5.27x
FCF / EV yield	1.48%
FCF yield	1.66%
Forward EV/Sales	4.22x
Forward P/E	68.8x
Forward P/S	3.77x
Graham number	16.8244
Graham upside	-66.7%
Industry forward P/E	71.56x
Industry P/E	86.08x
P/(FCF - SBC) ratio	66.92x
P/(OCF - SBC) ratio	34.39x
P/B ratio	2.69x
P/E ratio	77.47x
P/FCF ratio	60.24x
P/FFO ratio	25.69x
P/OCF ratio	32.54x
P/S ratio	4.7x
PEG ratio	5.13x
Price / tangible book value	3.66x
Price/EBITDA ratio	26.33x
Sector forward P/E	30.05x
Sector P/E	41.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	6.83%
EBITDA margin	17.86%
FCF margin	7.81%
Gross margin	19.28%
Operating margin	6.83%
Pretax margin	3.93%
Profit margin	4.83%
Profit per employee	$1M
Profitable quarters	5
Profitable years	1
Revenue per employee	$20.7M
ROA	2.09%
ROA (5Y)	1.17%
ROCE	3.23%
ROE	3.95%
ROE (5Y)	-2.45%
ROIC	3.26%
ROIC (5Y)	2%
SBC / revenue	0.78%
Tax / revenue	-0.96%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	157.49%
EPS growth (QoQ)	25.05%
EPS growth quarters	5
EPS growth years	3
Net income growth (Q)	208.9%
Net income growth (QoQ)	29.07%
Net income growth quarters	5
Net income growth years	3
OCF growth	42.13%
OCF growth (Q)	65.96%
OCF growth (QoQ)	46.32%
OCF growth 10Y	20.39%
OCF growth 3Y	38.84%
OCF growth 5Y	37.42%
Revenue growth	16.94%
Revenue growth (Q)	24.73%
Revenue growth (QoQ)	3.62%
Revenue growth 10Y	15.09%
Revenue growth 3Y	12.03%
Revenue growth 5Y	16.5%
Revenue growth quarters	18
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-166.5M
Depreciation and amortization	$243.7M
EBIT	$171.1M
EBITDA	$447.4M
EPS	$0.66
FCF per share	$0.84
Financing cash flow	$1B
Free cash flow	$195.5M
Free cash flow minus SBC	$176M
Funds from operations (FFO)	$359M
Gross profit	$482.9M
Income taxes	$-24M
Investing cash flow	$-1.4B
Net cash flow	$21.6M
Net income	$121M
Operating cash flow minus SBC	$342.5M
Operating income	$171.1M
Revenue	$2.5B
Stock-based compensation	$19.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$18.98
Debt / EBITDA	3.27
Debt / equity	0.42
Debt / FCF	8.02
Goodwill	$234.9M
Interest coverage	2.2
Net cash (debt)	$-1.4B
Net cash / market cap	-11.97%
Net debt / EBITDA	3.15
Net debt / equity	0.38
Net debt / FCF	7.21
Piotroski F-Score	5
Property, plant and equipment	$4.5B
Shareholders' equity	$3.7B
Tangible book value	$3.2B
Tangible book value per share	$16.55
Total assets	$5.7B
Total cash	$157.9M
Total debt	$1.6B
Total liabilities	$2B
WACC	8.09%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.49
Current ratio	1.31
Inventory turnover	101.25
Net working capital	$51.6M
Quick ratio	1.06
Working capital	$129.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-20.66%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-10-16
Dividend payment years	3
Dividend payout frequency	Quarterly
Dividend per share	$1.00
Dividend yield	1.95%
Ex-dividend date	2026-09-30
FCF payout ratio	119.25%
Last dividend	$0.25
Payout ratio	150.84%
Shareholder yield	-18.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$51.85
1D price change	0.59%
1M price change	-1.23%
1M total return	-0.75%
1W price change	-5.48%
1W total return	-5.48%
1Y price change	15.75%
1Y return CAGR	18.12%
1Y total return	18.11%
20-day SMA	$51.94
200-day SMA	$51.41
3M price change	-10.57%
3M total return	-10.13%
50-day SMA	$53.26
50-day SMA vs 200-day SMA	50over200
52-week high	$58.70
52-week high date	2026-07-28
52-week low	$43.33
52-week low date	2025-10-28
6M price change	2.11%
6M total return	3.1%
All-time high	$58.70
All-time high date	2026-07-28
All-time low	$12.63
All-time low date	2024-02-07
Average true range (ATR)	$1.40
Average volume	2.9M
Beta (1Y)	0.16
Beta (2Y)	0.34
Beta (5Y)	0.8
Change from 52-week high	-12.5%
Change from 52-week low	18.55%
Change from all-time high	-12.47%
Change from all-time low	306.81%
Change from open	2.64%
Day's gap	-2%
Dollar volume	$313.4M
High price	$51.51
Low price	$49.65
Monthly RSI	67.85
Open price	$50.04
Position in 52-week range	91.94%
Premarket change	-0.12%
Premarket close	$51.06
Premarket price	$51.00
Premarket volume	242
Previous close	$51.06
Price vs 150-day SMA	-0.91%
Price vs 20-day SMA	-1.08%
Price vs 200-day SMA	-0.06%
Price vs 50-day SMA	-3.52%
Relative volume	2.1
Return from IPO open	293.15%
Return from IPO price	321%
RSI	44.32
Sharpe ratio	0.61
Sortino ratio	1.1
Volume	6.1M
Weekly RSI	48.18
YTD price change	9.18%
YTD total return	10.83%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	229.7M
Float percentage	98.51%
Shares change (QoQ)	2.86%
Shares change (YoY)	20.66%
Shares held by insiders	0.59%
Shares held by institutions	99.74%
Shares outstanding	233.2M
Short % of float	13.85%
Short % of shares	13.64%
Short ratio	10.1 days

Deeper analysis on AHR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AHR report

Is a complete AHR research report available?

No complete published report is available for American Healthcare REIT, Inc. (AHR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

American Healthcare REIT, Inc. (AHR)

Price

Financial snapshot

Fair-value bridge

Latest news · AHR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AHR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AHR

Frequently asked questions